Creative Planning reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 38.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,941 shares of the company’s stock after selling 39,224 shares during the quarter. Creative Planning’s holdings in GE HealthCare Technologies were worth $5,813,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Capital Research Global Investors grew its holdings in shares of GE HealthCare Technologies by 5.2% in the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after purchasing an additional 2,647,204 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after acquiring an additional 4,107,746 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of GE HealthCare Technologies by 18.0% during the second quarter. The Manufacturers Life Insurance Company now owns 1,245,961 shares of the company’s stock worth $97,088,000 after acquiring an additional 189,956 shares during the period. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of GE HealthCare Technologies by 2.1% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,025,320 shares of the company’s stock valued at $93,212,000 after acquiring an additional 20,776 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in GE HealthCare Technologies by 6.8% in the second quarter. Envestnet Asset Management Inc. now owns 979,031 shares of the company’s stock valued at $76,286,000 after purchasing an additional 61,935 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.27% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Stock Performance
NASDAQ GEHC opened at $89.29 on Thursday. The company has a fifty day moving average of $88.16 and a two-hundred day moving average of $83.37. The company has a market capitalization of $40.76 billion, a PE ratio of 26.11, a P/E/G ratio of 3.39 and a beta of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.55. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- What to Know About Investing in Penny Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Using the MarketBeat Dividend Yield Calculator
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Use the MarketBeat Dividend Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.